CMS Considers Covering DNA Stool Test For Colorectal Cancer

CMS is considering national coverage for aDNA stool test as an alternative to a colonoscopy or sigmoidoscopy for colon cancer screening, the agency announced Aug. 1

More from Archive

More from Medtech Insight